Stay updated on SKI-G-801 Dose Study in AML Clinical Trial

Sign up to get notified when there's something new on the SKI-G-801 Dose Study in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SKI-G-801 Dose Study in AML Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The record was updated in 2024 with a new last update date and QC status; no changes to the core study design, eligibility criteria, or outcomes.
    Difference
    0.1%
    Check dated 2026-03-25T21:03:48.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision: v3.5.0 has been added and v3.4.3 has been removed.
    Difference
    0.1%
    Check dated 2026-03-18T15:53:29.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-11T15:25:33.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The two screenshots reflect the same study record without changes to core content such as study title, conditions, interventions, eligibility criteria, or outcome measures.
    Difference
    0.1%
    Check dated 2026-03-04T12:46:41.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Added a new revision tag v3.4.2 and removed an outdated funding-status notice (and the earlier v3.4.1 revision).
    Difference
    0.5%
    Check dated 2026-02-11T02:33:44.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and where to check status, and updated the page revision to v3.4.1 (removing v3.4.0).
    Difference
    0.5%
    Check dated 2026-02-03T23:49:16.000Z thumbnail image

Stay in the know with updates to SKI-G-801 Dose Study in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SKI-G-801 Dose Study in AML Clinical Trial page.